The global urinary tract infection testing market is expected to grow at a significant rate in the coming years, driven by several factors. These include increasing incidence of urinary tract infections, HAIs; and expanding indications and growing demand for screening and diagnosis of such conditions. The global market currently stands at USD 593.7 Million in 2023, and it is projected to grow to USD 1.1 Billion by 2033, it is further projected to expand at a CAGR of 6.0% over the forecast period (2023-2033).
One of the most prevalent infectious diseases caused by bacteria is urinary tract infection. Complicated urinary tract infection (cUTI) can affect anyone, regardless of gender or age, and is usually caused by anatomical or functional abnormalities in the urinary system.
The development of multidrug-resistant bacteria is increasingly common in cUTI, and the number of multidrug-resistant bacteria has increased, resulting in an increase in cUTI cases worldwide.
Chronic diseases are becoming more common all around the world. Diabetes mellitus, prolonged institutionalisation, neurological disorders, and persistent indwelling catheterization are all risk factors for urinary tract infection. Over the projected period, these factors are expected to raise the number of UTI patients and fuel the growth of the UTI testing market.
Increased testing demand may result from more people seeking medical attention for their symptoms as their understanding of UTIs grows. Over the last three decades, the burden of UTIs has varied according to sociodemographic status, country, location, gender, and age. The overall increasing burden recommends that suitable preventative and treatment strategies, particularly in high-income countries and civilizations with ageing populations, should be improved.
Key Takeaways from Market Study: Urinary Tract Infection Testing Market
- Growing Incidence of UTIs: UTIs are a common health issue, especially among women. The market for UTI testing is likely to grow due to an increasing prevalence of UTIs worldwide.
- Technological Advancements: Advances in diagnostic technologies and the development of rapid and accurate UTI testing methods may contribute to improved detection rates and patient outcomes.
- Point-of-Care Testing (POCT) On the Rise: The adoption of point-of-care testing (POCT) for UTIs is likely to increase, as it enables faster results and quicker initiation of treatment.
- Increasing Awareness and Healthcare Access: Improved awareness about UTIs and better access to healthcare services can lead to early diagnosis and management of UTIs, thus driving the market growth.
- Home Testing Kits: The availability of over-the-counter UTI testing kits for home use may gain popularity, offering convenience to individuals seeking quick testing and self-monitoring.
- Focus on Prevention and Proactive Measures: Healthcare providers may emphasize preventive measures to reduce the incidence of UTIs, impacting the overall demand for testing.
- Emerging Markets: UTI testing may witness growth in emerging markets as healthcare infrastructure improves and disposable income rises in these regions.
“Growing cases of developing urinary tract infections among immune-compromised people or those with chronic health conditions are likely to promote the market growth” says an analyst of Future Market Insights.
Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!
Key insights into the UTI testing market by country may include:
- North America:
- The United States and Canada have well-established healthcare systems and advanced diagnostic infrastructure, leading to a robust UTI testing market.
- The increasing geriatric population, as well as the rise in chronic diseases, have contributed to the growth of UTI testing in this region.
- Europe:
- European countries, such as Germany, the United Kingdom, France, and Italy, have strong healthcare systems and a high demand for advanced diagnostic technologies.
- Growing awareness of UTIs and the importance of early diagnosis have driven the market in this region.
- Asia-Pacific:
- Countries like China, Japan, India, and South Korea have a large population base, contributing to a significant portion of the UTI testing market.
- Increasing healthcare expenditure and a rising focus on preventive healthcare measures have also supported the market’s growth.
- Latin America:
- Brazil and Mexico are major contributors to the UTI testing market in Latin America.
- Improving healthcare infrastructure and rising awareness about UTIs have positively impacted the market.
- Middle East and Africa:
- Gulf Cooperation Council (GCC) countries, such as Saudi Arabia and the United Arab Emirates, have shown increased adoption of advanced diagnostics, including UTI testing.
- The market in other African countries is growing steadily, driven by improving healthcare access and awareness.
Factors influencing the UTI testing market may include technological advancements in diagnostic tests, increasing prevalence of UTIs due to lifestyle changes, growing awareness of the importance of early diagnosis, and initiatives by governments and healthcare organizations to improve healthcare infrastructure.
Top Companies Profiled:
- ACON Laboratories Inc.
- Cardinal Health Inc.
- Danaher Corporation
- SYSMEX CORPORATION
- Abbott Laboratories
- Bio-Rad Laboratories
- Roche AG
- LabCorp (Laboratory Corporation of America Holdings).
- Stryker Corporation
- Thermo Fisher Scientific, Inc.
Key Market Segments Covered in the Urinary Tract Infection Testing Industry Research
By Tests:
- Urinalysis
- Urine Cultures
- Susceptibility Testing
By Test Kits:
- Home Test Kits
- Laboratory Test Kits
By Indication:
- Cystitis
- Urethritis
- Pyelonephritis
By End User:
- Hospitals
- Nephropathy Clinics
- Diagnostic Laboratories
- others
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
